A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients With AL Amyloidosis
Condition:   AL Amyloidosis Interventions:   Drug: CAEL-101;   Other: Placebo;   Drug: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) Sponsors:   Caelum Biosciences;   IQVIA Biotech Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2020 Category: Research Source Type: clinical trials

Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis
Condition:   Amyloidosis; Systemic Interventions:   Drug: Daratumumab;   Drug: Bortezomib;   Drug: Dexamethasone Sponsors:   Peking Union Medical College Hospital;   Xian-Janssen Pharmaceutical Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2020 Category: Research Source Type: clinical trials

Cardiac Amyloidosis : Diagnostic Using Red Flag Signals
Condition:   Cardiac Amyloidosis Intervention:   Procedure: diagnostic algorithm Sponsors:   University Hospital Center of Martinique;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2020 Category: Research Source Type: clinical trials

Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Bidimensional Shear Wave Elastography) in Patients With Transthyretin Amyloidosis
Condition:   Amyloidosis Intervention:   Procedure: Shear wave elastography Sponsors:   Fábio Fernandes;   Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 2, 2020 Category: Research Source Type: clinical trials

Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
Condition:   TTR Cardiac Amyloidosis Interventions:   Device: Biotronic 3 implant of device;   Device: Biotonic 3 explant of device Sponsor:   Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2020 Category: Research Source Type: clinical trials

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
Condition:   AL Amyloidosis Intervention:   Drug: [18F]Florbetaben Sponsor:   IRCCS Policlinico S. Matteo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2020 Category: Research Source Type: clinical trials

Morpho-functional Cardiac Modifications in Treated Mutated Transthyretin Cardiac Amyloidosis
Condition:   Cardiac Amyloidosis Intervention:   Sponsors:   University of Messina;   Campisi Mariapaola Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2020 Category: Research Source Type: clinical trials